|
1
|
Berry SJ, Coffey DS, Walsh PC and Ewing
LL: The development of human benign prostatic hyperplasia with age.
J Urol. 132:474–479. 1984.PubMed/NCBI
|
|
2
|
Liu XY, Li DM, Zhang XF, Wu JH and Sun ZY:
Mitosis orientation in prostate epithelial cells changed by
endocrine effect. Acta Pharmacol Sin. 29:226–229. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gao W: Androgen receptor as a therapeutic
target. Adv Drug Deliv Rev. 62:1277–1284. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chatterjee B: The role of the androgen
receptor in the development of prostatic hyperplasia and prostate
cancer. Mol Cell Biochem. 253:89–101. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Beltrami AP, Cesselli D and Beltrami CA:
At the stem of youth and health. Pharmacol Ther. 129:3–20. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Isaacs JT and Coffey DS: Etiology and
disease process of benign prostatic hyperplasia. Prostate Suppl.
2:33–50. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mansour FH and Pestov DG: Separation of
long RNA by agarose-formaldehyde gel electrophoresis. Anal Biochem.
441:18–20. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vignozzi L, Gacci M, Cellai I, Santi R,
Corona G, Morelli A, Rastrelli G, Comeglio P, Sebastanelli A,
Maneschi E, et al: Fat boosts, while androgen receptor activation
counteracts, BPH-associated prostate inflammation. Prostate.
73:789–800. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiang-Yun L, Ying-Wen X, Chen-Jing X,
Jiu-Jiu W, Qi P, Bo G and Zu-Yue S: Possible mechanism of benign
prostatic hyperplasia induced by androgen-estrogen ratios in
castrated rats. Indian J Pharmacol. 42:312–317. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hartman J, Ström A and Gustafsson JÅ:
Current concepts and significance of estrogen receptor β in
prostate cancer. Steroids. 77:1262–1266. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
13
|
Ye X, Zerlanko B, Kennedy A, Banumathy G,
Zhang R and Adams PD: Downregulation of Wnt signaling is a trigger
for formation of facultative heterochromatin and onset of cell
senescence in primary human cells. Mol Cell. 27:183–196. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Levasseur R, Lacombe D and de Vernejoul
MC: LRP5 mutations in osteoporosis-pseudoglioma syndrome and
high-bone-mass disorders. Joint Bone Spine. 72:207–214. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davidson G, Mao B, del Barco Barrantes I
and Niehrs C: Kremen proteins interact with Dickkopf1 to regulate
anteroposterior CNS patterning. Development. 129:5587–5596. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abarzua F, Sakaguchi M, Takaishi M, Nasu
Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H and Huh NH:
Adenovirus-mediated overexpression of REIC/Dkk-3 selectively
induces apoptosis in human prostate cancer cells through activation
of c-Jun-NH2-kinase. Cancer Res. 65:9617–9622. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hsieh SY, Hsieh PS, Chiu CT and Chen WY:
Dickkopf-3/REIC functions as a suppressor gene of tumor growth.
Oncogene. 23:9183–9189. 2004.PubMed/NCBI
|
|
18
|
Kawano Y, Kitaoka M, Hamada Y, Walker MM,
Waxman J and Kypta RM: Regulation of prostate cell growth and
morphogenesis by Dickkopf-3. Oncogene. 25:6528–6537. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li H, Wu C, Gu X and Xiong C: A novel
application of cell-free seminal mRNA: Non-invasive identification
of the presence of germ cells or complete obstruction in men with
azoospermia. Hum Reprod. 27:991–997. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu B, Harihan A, Rakshit S, Dressler GR
and Wellik DM: The role of Pax2 in mouse prostate development.
Prostate. 72:217–224. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thielen JL, Volzing KG, Collier LS, Green
LE, Largaespada DA and Marker PC: Markers of prostate
region-specific epithelial identity define anatomical locations in
the mouse prostate that are molecularly similar to human prostate
cancers. Differentiation. 75:49–61. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ran L, He W, Zhu X, Zhou Q and Gou X:
Comparison of fluid absorption between transurethral enucleation
and transurethral resection for benign prostate hyperplasia. Urol
Int. 91:26–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Newton CJ, Ran G, Xie YX, Bilko D,
Burgoyne CH, Adams I, Abidia A, McCollum PT and Atkin SL:
Statin-induced apoptosis of vascular endothelial cells is blocked
by dexamethasone. J Endocrinol. 174:7–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Niehrs C and Acebron SP: Mitotic and
mitogenic Wnt signalling. EMBO J. 31:2705–2713. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nandan MO, Chanchevalap S, Dalton WB and
Yang VW: Krüppel-like factor 5 promotes mitosis by activating the
cyclin B1/Cdc2 complex during oncogenic Ras-mediated
transformation. FEBS Lett. 579:4757–4762. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Antonarakis ES, Lu C, Luber B, Wang H,
Chen Y, Nakazawa M, Nadal R, Paller CJ, Denmeade SR, Carducci MA,
et al: Androgen receptor splice variant 7 and efficacy of taxane
chemotherapy in patients with metastatic castration-resistant
prostate cancer. JAMA Oncol. 1:582–591. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mukhopadhyay NK, Cinar B, Mukhopadhyay L,
Lutchman M, Ferdinand AS, Kim J, Chung LW, Adam RM, Ray SK, Leiter
AB, et al: The zinc finger protein ras-responsive element binding
protein-1 is a coregulator of the androgen receptor: Implications
for the role of the Ras pathway in enhancing androgenic signaling
in prostate cancer. Mol Endocrinol. 21:2056–2070. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choi HJ and Zhu BT: Critical role of
cyclin B1/Cdc2 up-regulation in the induction of mitotic
prometaphase arrest in human breast cancer cells treated with
2-methoxyestradiol. Biochim Biophys Acta. 1823:1306–1315. 2012.
View Article : Google Scholar : PubMed/NCBI
|
